Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 30, 2022KardiologiiaOpen Access

The use of systemic immune-inflammation index to predict new onset atrial fibrillation in the context of acute coronary syndrome

View Full Paper
Ask AI
Bookmark
Share

Why the study?

To determine the relationship between the systemic immune-inflammation index (SII) and new onset atrial fibrillation (NOAF) in patients with acute coronary syndrome (ACS), and assess its predictive utility.

Does the systemic immune-inflammation index predict new onset atrial fibrillation in patients with acute coronary syndrome?

Population

622 patients diagnosed with ACS

Comparison

Patients with NOAF vs control group without NOAF

Authors

MSMuhammet Raşit SayınAÖAhmet ÖzderyaAKAli Hakan Konuş

Discussion

Loading...

Member takes

Overview

SII may predict NOAF in ACS; hypothesis-generating and requires prospective validation before clinical use.

Structured PICO

Does the systemic immune-inflammation index predict new onset atrial fibrillation in patients with acute coronary syndrome?

P
Population
622 patients diagnosed with acute coronary syndrome (ACS)
I
Intervention
Systemic immune-inflammation index (SII)
O
Outcome
New onset atrial fibrillation (NOAF)hard clinical

The systemic immune-inflammation index is an independent predictor of new onset atrial fibrillation in patients with acute coronary syndrome.

Cite This Study

Sayın et al. (2022) studied this question.

synapsesocial.com/papers/6a7df7c55d36433ac2188010https://doi.org/10.18087/cardio.2022.8.n1986
View Full Paper
Ask AI
Bookmark
Share